Asahi Kasei Corporation (3407.T)
Tokyo - Tokyo Delayed price. Currency in JPY
Add to watchlist
At close: 03:15PM JST
| Previous close | 1,105.50 |
| Open | 1,105.00 |
| Bid | 1,101.50 x 0 |
| Ask | 1,101.50 x 0 |
| Day's range | 1,098.50 - 1,114.00 |
| 52-week range | 896.00 - 1,148.00 |
| Volume | |
| Avg. volume | 4,108,241 |
| Market cap | 1.526T |
| Beta (5Y monthly) | 0.75 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -71.01 |
| Earnings date | 09 May 2024 |
| Forward dividend & yield | 36.00 (3.27%) |
| Ex-dividend date | 28 Mar 2024 |
| 1y target est | 1,119.10 |
Business WireAsahi Kasei Bioprocess to Unveil THESYS™ ACS ERGO Synthesis Column at TIDES USA
TOKYO & NEW YORK & DÜSSELDORF, Germany, May 02, 2024--Asahi Kasei Bioprocess' (AKB) THESYS™ ACS ERGO synthesis column will be on display and demonstrated at Booth 213 at TIDES USA 2024.
Business WireAsahi Kasei to Construct a Lithium-ion Battery Separator Plant in Canada
TOKYO & NEW YORK & DÜSSELDORF, Germany, April 25, 2024--Asahi Kasei plans to construct an integrated plant in Ontario, Canada for base film manufacturing and coating of Hipore™ wet-process LIB separator.
Business WireAsahi Kasei Bioprocess and Axolabs Announce Strategic Partnership to Accelerate Oligonucleotide Therapeutics Development
TOKYO & NEW YORK & DÜSSELDORF, Germany, April 11, 2024--Asahi Kasei Bioprocess (AKB) and Axolabs have announced a strategic partnership in the burgeoning field of oligonucleotide therapeutics.
© 2024 Yahoo. All rights reserved.